Selection of recombinant, library-derived antibody fragments against p24 for human immunodeficiency virus type 1 diagnostics

被引:12
作者
de Haard, HJW
Kazemier, B
Koolen, MJM
Nijholt, LJ
Meloen, RH
van Gemen, B
Hoogenboom, HR
Arends, JW
机构
[1] Organon Teknika, Biosci Res Unit, Boxtel, Netherlands
[2] DLO, Inst Anim Sci & Hlth, ID, Dept Mol Recognit, Lelystad, Netherlands
[3] Maastricht Univ, Maastricht, Netherlands
[4] Univ Hosp, Dept Pathol, CESAME, Maastricht, Netherlands
关键词
D O I
10.1128/CDLI.5.5.636-644.1998
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
By application of combinatorial library technology, we generated the first recombinant antibody fragments directed against the major capsid protein p24 of human immunodeficiency virus type 1 (HIV-1). A library of single-chain Fv fragments (scFvs) was constructed by using the antibody variable-region (V) genes of B cells derived from the spleen of a viral lysate-immunized mouse. Antibodies were selected by panning or by enrichment with biotinylated antigen, yielding four different families of antibody fragments. The different types of scFvs were characterized by affinity measurements, by antigen recognition on Western blots, and by pepscan analysis. The epitope of one of the scFvs is located near the residues involved in CypA binding, thereby making it an attractive candidate for therapeutic applications. Comparison of the V gene sequence of this scFV with that of a previously described monoclonal antibody reactive against this immunodominant epitope revealed the usage of the identical combination of V-H and V-kappa regions. Thus, this is one of the rare examples in which the original combination in a library-derived antibody fragment was retrieved. After appropriate affinity and format improvements, the best of our recombinant scFvs may form the basis for a sensitive p24 assay as a measure of viral load. In addition, anti-p24 scFvs could be expressed as intracellular antibodies (intrabodies) to aid in the treatment of HIV infections.
引用
收藏
页码:636 / 644
页数:9
相关论文
共 71 条
[1]   Selection and evolution of high-affinity human anti-viral antibodies [J].
Barbas, CF ;
Burton, DR .
TRENDS IN BIOTECHNOLOGY, 1996, 14 (07) :230-234
[2]   MOLECULAR PROFILE OF AN ANTIBODY-RESPONSE TO HIV-1 AS PROBED BY COMBINATORIAL LIBRARIES [J].
BARBAS, CF ;
COLLET, TA ;
AMBERG, W ;
ROBEN, P ;
BINLEY, JM ;
HOEKSTRA, D ;
CABABA, D ;
JONES, TM ;
WILLIAMSON, RA ;
PILKINGTON, GR ;
HAIGWOOD, NL ;
CABEZAS, E ;
SATTERTHWAIT, AC ;
SANZ, I ;
BURTON, DR .
JOURNAL OF MOLECULAR BIOLOGY, 1993, 230 (03) :812-823
[3]   HIGH-LEVELS OF CIRCULATING RNA IN PATIENTS WITH SYMPTOMATIC HIV-1 INFECTION [J].
BAUMBERGER, C ;
KINLOCHDELOES, S ;
YERLY, S ;
HIRSCHEL, B ;
PERRIN, L .
AIDS, 1993, 7 :S59-S64
[4]  
BERMAN M, UNPUB
[5]   MODE OF ACTION OF SDZ NIM-811, A NONIMMUNOSUPPRESSIVE CYCLOSPORINE-A ANALOG WITH ACTIVITY AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1 - INTERFERENCE WITH HIV PROTEIN-CYCLOPHILIN-A INTERACTIONS [J].
BILLICH, A ;
HAMMERSCHMID, F ;
PEICHL, P ;
WENGER, R ;
ZENKE, G ;
QUESNIAUX, V ;
ROSENWIRTH, B .
JOURNAL OF VIROLOGY, 1995, 69 (04) :2451-2461
[6]   EFFECTS OF BACTERIOPHAGE-F1 GENE-III PROTEIN ON THE HOST-CELL MEMBRANE [J].
BOEKE, JD ;
MODEL, P ;
ZINDER, ND .
MOLECULAR & GENERAL GENETICS, 1982, 186 (02) :185-192
[7]   Simple monitoring of antiretroviral therapy with a signal-amplification-boosted HIV-1 p24 antigen assay with heat-denatured plasma [J].
Boni, J ;
Opravil, M ;
Tomasik, Z ;
Rothen, M ;
Bisset, L ;
Grob, PJ ;
Luthy, R ;
Schupbach, J .
AIDS, 1997, 11 (06) :F47-F52
[8]   Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription [J].
Braaten, D ;
Franke, EK ;
Luban, J .
JOURNAL OF VIROLOGY, 1996, 70 (06) :3551-3560
[9]   ESTIMATION OF CURRENT HUMAN-IMMUNODEFICIENCY-VIRUS INCIDENCE RATES FROM A CROSS-SECTIONAL SURVEY USING EARLY DIAGNOSTIC-TESTS [J].
BROOKMEYER, R ;
QUINN, TC .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 141 (02) :166-172
[10]   TIME-COURSE OF DETECTION OF VIRAL AND SEROLOGIC MARKERS PRECEDING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEROCONVERSION - IMPLICATIONS FOR SCREENING OF BLOOD AND TISSUE DONORS [J].
BUSCH, MP ;
LEE, LLL ;
SATTEN, GA ;
HENRARD, DR ;
FARZADEGAN, H ;
NELSON, KE ;
READ, S ;
DODD, RY ;
PETERSEN, LR .
TRANSFUSION, 1995, 35 (02) :91-97